Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ARGX argenx SE > Detailed Quotes

ARGX argenx SE

Watchlist
380.900
-1.200-0.31%
Close  01/27 16:00 ET
380.9000.0000.00%
Post Mkt Price 01/27 16:00 ET
High
385.270
Open
371.850
Turnover
112.68M
Low
371.850
Pre Close
382.100
Volume
297.30K
Market Cap
21.07B
P/E(TTM)
Loss
52wk High
407.930
Shares
55.32M
P/E(Static)
Loss
52wk Low
256.440
Float Cap
20.88B
Bid/Ask %
33.33%
Historical High
407.930
Shs Float
54.82M
Volume Ratio
1.54
Historical Low
19.360
Dividend TTM
--
Div Yield TTM
--
P/B
7.09
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.54%
Amplitude
3.51%
Avg Price
379.012
Lot Size
1
Float Cap
20.88B
Bid/Ask %
33.33%
Historical High
407.930
Shs Float
54.82M
Volume Ratio
1.54
Historical Low
19.360
Dividend TTM
--
P/B
7.09
Dividend LFY
--
Turnover Ratio
0.54%
Amplitude
3.51%
Avg Price
379.012
Lot Size
1
Price Forecast

News

Comment

Company Overview More
argenx SE operates as a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. It operates from the Netherlands, Belgium, the United States of America, Japan, Switzerland, Germany and France. The firm partnering with academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. It evaluates efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Breda, the Netherlands.
CEO: Mr. Tim Van Hauwermeiren
Market: NASDAQ
Listing Date: 05/18/2017
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist